Evidence map›Paper›PMID 41792502›Full record

ArticleCancer gene therapy2026

HAUS1-mediated activation of CDK4 transcription enhances proliferation, invasion and migration in hepatocellular carcinoma.

Lei Tang, Jun Zhao, Rongyuan Liang, Jiale Yang, Caiwei Chen, Zhonghuo Chen, Xiaofei Tao, Jianwei Yi, Taozhi Yu, Kai Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lei Tang *Jiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jun Zhao *Department of Hepatobiliary Surgery, Jingdezhen NO.1 People's Hospital, Jingdezhen, China.
Rongyuan Liang *Jiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jiale YangJiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Caiwei ChenNanchang University Queen Mary School, Nanchang University, Nanchang, China.
Zhonghuo ChenJiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Xiaofei TaoJiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jianwei YiJiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Taozhi YuJiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Kai WangJiangxi Province Key Laboratory of Molecular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. ndefy07021@ncu.edu.cn.ORCID http://orcid.org/0000-0002-8394-348X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is distinguished by aggressive proliferation, invasion, and migration, with its underlying molecular mechanisms remaining largely elusive.This study delves into the molecular mechanisms underlying HAUS1's role in HCC progression, focusing on its regulatory relationship with Cyclin-Dependent Kinase 4 (CDK4). We analyzed 34 HCC tissue specimens and conducted in vitro assays to evaluate HAUS1's impact on cell proliferation, invasion, migration, cycle and apoptosis. Potential molecules regulated by HAUS1 that could influence HCC function were further screened. Notably, HAUS1 was shown to activate CDK4 (Cyclin-Dependent Kinase 4) transcription, establishing a regulatory nexus where HAUS1-induced CDK4 expression exacerbates HCC malignancy. In vivo studies reinforced these findings, evidencing that HAUS1 influences tumor growth in xenograft models. Collectively, our research elucidates HAUS1's oncogenic role in HCC, mediated through CDK4 activation, and highlights its potential as a therapeutic target in HCC therapy. Mechanistic diagram illustrating how HAUS1 activates CDK4 transcription to promote proliferation, invasion and migration in HCC.

Indexed as

Carcinoma, HepatocellularCyclin-Dependent Kinase 4Liver NeoplasmsAnimalsApoptosisCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMiceNeoplasm InvasivenessCDK4 protein, humanCyclin-Dependent Kinase 4

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.